Difficulty: Medium
Average Score: 83%
Practice
Which of the following agent enhance bioavailability for Parkinson Disease
Correct answer
C
Rationale
In the context of Parkinson's disease treatment, the correct answer is Entacapone (Option C) because it belongs to a class of drugs known as COMT inhibitors. Entacapone works by inhibiting the enzyme catechol-O-methyltransferase (COMT), which helps increase the bioavailability of levodopa in the brain, thus enhancing its effectiveness in managing Parkinson's symptoms.
Option A, Ropinirole, is a dopamine agonist used to treat Parkinson's disease symptoms by directly stimulating dopamine receptors. However, it does not enhance levodopa bioavailability like COMT inhibitors do.
Option B, Amantadine, is an antiviral drug that also has some efficacy in treating Parkinson's symptoms, but it does not enhance levodopa bioavailability.
Option D, Selegiline, is a monoamine oxidase type B (MAO-B) inhibitor that helps prevent the breakdown of dopamine in the brain, but it does not directly enhance levodopa bioavailability.
Understanding the mechanism of action of different drugs used in Parkinson's disease management is crucial for healthcare providers to make informed treatment decisions and optimize patient outcomes. By knowing how each drug works, healthcare professionals can tailor treatment plans to individual patients based on their specific needs and responses to different medications.
Option A, Ropinirole, is a dopamine agonist used to treat Parkinson's disease symptoms by directly stimulating dopamine receptors. However, it does not enhance levodopa bioavailability like COMT inhibitors do.
Option B, Amantadine, is an antiviral drug that also has some efficacy in treating Parkinson's symptoms, but it does not enhance levodopa bioavailability.
Option D, Selegiline, is a monoamine oxidase type B (MAO-B) inhibitor that helps prevent the breakdown of dopamine in the brain, but it does not directly enhance levodopa bioavailability.
Understanding the mechanism of action of different drugs used in Parkinson's disease management is crucial for healthcare providers to make informed treatment decisions and optimize patient outcomes. By knowing how each drug works, healthcare professionals can tailor treatment plans to individual patients based on their specific needs and responses to different medications.